Jesse Plemons admitted he is aware everyone is going to think he used Ozempic for his weight loss
The Ozempic drug is certainly a hot topic right now in Hollywood. Some celebrities have insisted they have never touched it while others have remarked at how great it was for their weight loss.
Celebs Oprah and Rebel Wilson have admitted to using weight loss medications, while Kelly Osbourne has said her weight loss was all her.
Advert
The conversation around using Ozempic as a weight loss drug opposed to its intended use as an injection to manage blood glucose levels in people with type two diabetes continues to be divisive.
If you log on to social media, any celebrity who has dropped a few pounds recently is immediately accused of using the drug, regardless of any evidence.
Actor Jesse Plemons, often remembered for his unnerving character Todd in Breaking Bad, has admitted he is aware of the rumors circulating him for his own weight loss.
Advert
Speaking to the Los Angeles times in a June 13 article, he insisted he simply changed his lifestyle to shed the pounds.
"It's really unfortunate that I decided to get healthy when everyone decided to take Ozempic,” he said.
"It doesn't matter, everyone's going to think I took Ozempic anyways. But what it was was getting older and — I hate even getting specific because then it turns into a whole thing.
“Several people talked to me about intermittent fasting and I just gave it a shot and [was] surprised at how quickly it was effective.”
Advert
“So I lost a little bit...and then felt like I was in the rhythm, I was feeling better, and something shifted in my head. I just sort of got a handle on it.”
The drug will likely continue to prove divisive and attributed to celebrities for the foreseeable future.
In 2022, the National Institute for Health and Care Excellence (NICE) drafted guidelines that the drug can be prescribed to people with a body mass index of at least 30, as well as people who have 'at least one weight-related condition'.
Advert
The drug does come with side effects, including nausea, stomach pain, and vomiting.
Now, the FDA has clarified its position on Ozempic, saying that the benefits provided by Ozempic outweigh the risks.
In a November 2023 statement, a spokesperson for the FDA said: "The FDA maintains that the benefits of Ozempic outweigh its risks when used according to the approved labeling."
UNILAD has contacted representatives of Jesse Plemons for comment.
Gerrard Kaonga